Premium
UroGen Pharma Ltd (0XOD)
LSE
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-06-22 | Dr. Mark P. SchoenbergChief Medical Officer | -10,00k | 350,10k | Automatic Disposition | 35,01 | 129,76k | -7,15% |
| 2026-06-08 | Dr. Mark P. SchoenbergChief Medical Officer | 4,78k | 0,00 | Derivative Exercise and Retained Stock | - | 139,76k | 3,54% |
| 2026-06-08 | Dr. Mark P. SchoenbergChief Medical Officer | -5,22k | 142,56k | Derivative Exercise and Sale | 27,30 | 139,76k | - |
| 2026-05-26 | Mr. James A. RobinsonIndependent Director | 2,00k | 0,00 | Derivative Exercise and Retained Stock | - | 6,00k | 50,00% |
| 2026-05-08 | Dr. Mark P. SchoenbergChief Medical Officer | -10,00k | 300,00k | Automatic Disposition | 30,00 | 134,99k | -6,90% |
| 2025-02-26 | Mr. James A. RobinsonIndependent Director | 2,00k | 0,00 | Derivative Exercise and Retained Stock | - | 4,00k | 100,00% |
| 2026-01-31 | Mr. Jason Drew SmithGeneral Counsel, CCO & Corporate Secretary | 8,02k | 0,00 | Derivative Exercise and Retained Stock | - | 55,59k | 16,86% |
| 2026-01-31 | Mr. Jason Drew SmithGeneral Counsel, CCO & Corporate Secretary | -7,48k | 147,26k | Derivative Exercise and Sale | 19,69 | 55,59k | - |
| 2026-02-03 | Dr. Mark P. SchoenbergChief Medical Officer | -7,37k | 145,17k | Vente | 19,69 | 144,99k | -4,84% |
| 2026-01-31 | Dr. Mark P. SchoenbergChief Medical Officer | 13,33k | 0,00 | Derivative Exercise and Retained Stock | - | 142,36k | 10,33% |
| 2025-11-26 | Dr. Stuart HoldenIndependent Director | 2,00k | 0,00 | Derivative Exercise and Retained Stock | - | 2,00k | - |
| 2025-11-26 | Ms. Cynthia Marie ButittaIndependent Director | 2,00k | 0,00 | Derivative Exercise and Retained Stock | - | 2,00k | - |
| 2025-11-26 | Mr. James A. RobinsonIndependent Director | 2,00k | 0,00 | Derivative Exercise and Retained Stock | - | 2,00k | - |
| 2025-11-26 | Dr. Leana S. WenIndependent Director | 2,00k | 0,00 | Derivative Exercise and Retained Stock | - | 2,00k | - |
| 2025-11-26 | Mr. Daniel G. WildmanIndependent Director | 2,00k | 0,00 | Derivative Exercise and Retained Stock | - | 2,00k | - |
| 2025-11-19 | Dr. Mark P. SchoenbergChief Medical Officer | -10,00k | 250,00k | Automatic Disposition | 25,00 | 139,03k | -6,71% |
| 2025-10-08 | Mr. Christopher DegnanCFO | 2,28k | 0,00 | Derivative Exercise and Retained Stock | - | 2,28k | - |
| 2025-10-08 | Mr. Christopher DegnanCFO | -2,20k | 37,12k | Derivative Exercise and Sale | 16,85 | 2,28k | - |
| 2025-09-07 | Dr. Mark P. SchoenbergChief Medical Officer | 796,00 | 0,00 | Derivative Exercise and Retained Stock | - | 149,03k | 0,54% |
| 2025-09-07 | Dr. Mark P. SchoenbergChief Medical Officer | -871,00 | 16,64k | Derivative Exercise and Sale | 19,11 | 149,03k | - |
| 2025-09-07 | Mr. Jason Drew SmithGeneral Counsel, CCO & Corporate Secretary | 1,81k | 0,00 | Derivative Exercise and Retained Stock | - | 43,31k | 4,37% |
| 2025-09-07 | Mr. Jason Drew SmithGeneral Counsel, CCO & Corporate Secretary | -1,52k | 29,05k | Derivative Exercise and Sale | 19,11 | 43,31k | - |
| 2025-08-11 | Dr. Mark P. SchoenbergChief Medical Officer | -10,00k | 176,90k | Vente | 17,69 | 148,23k | -6,32% |
| 2025-07-28 | Mr. Jason Drew SmithGeneral Counsel, CCO & Corporate Secretary | -7,52k | 143,97k | Vente | 19,14 | 41,49k | -15,35% |
| 2025-07-28 | Dr. Mark P. SchoenbergChief Medical Officer | 4,85k | 0,00 | Derivative Exercise and Retained Stock | - | 158,23k | 3,16% |
| 2025-07-28 | Dr. Mark P. SchoenbergChief Medical Officer | -5,15k | 98,55k | Derivative Exercise and Sale | 19,14 | 158,23k | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
